Klotho Therapeutics Company

Focused on development and commercialization of recombinant human Klotho proteins to prevent and treat kidney disease and other diseases.


Investors

Total Funding: 10000000
Headquarters: San Diego, California, United States
Funding Status: Early Stage Venture
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Last Funding Type: Series A
Technology: Geroscience
Investor Type: Early Stage Venture
Last Funding Date: 2017
Investors Number: 1
Founded Date: 2016
Industry: Biotechnology, Health Care